Hana Kostrhunova
Brno, JM 61200, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Chirality affects biological activity and interactions of azacryptands with alternative DNA structures.
Journal: Bioorganic chemistry
Published: March 30, 2026
Crizotinib- or Ceritinib-Conjugated Platinum(IV) Prodrugs As Potent Multiaction Agents Inducing Antiproliferative Effects in 2D and 3D Cancer Cell Models.
Journal: Journal of medicinal chemistry
Published: November 10, 2025
Excited-State Cis and Trans Pt(IV) Diamine Anticancer Complexes.
Journal: Inorganic chemistry
Published: May 28, 2025
Antitumor platinum(II) complex 56MESS binds to DNA G-quadruplexes, downregulates expression of c-MYC and k-RAS oncogenes, and triggers DNA damage in cancer cells.
Journal: Chemico-biological interactions
Published: January 09, 2025
A Novel Substituted Benzo[g]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.
Journal: Journal of medicinal chemistry
Published: December 02, 2024
Cisplatin-eugenol Pt(IV) prodrugs target colon cancer stem cells: A novel strategy for enhanced anticancer efficacy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 11, 2024
Ni(II) Cylinders Damage DNA in Cancer Cells and Preferentially Bind Y-Shaped DNA Three-Way Junctions Blocking DNA Synthesis.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: August 08, 2024
Multiaction Pt(IV) Prodrugs Releasing Cisplatin and Dasatinib Are Potent Anticancer and Anti-Invasive Agents Displaying Synergism between the Two Drugs.
Journal: Journal of medicinal chemistry
Published: May 31, 2024
Novel 2-(5-Arylthiophen-2-yl)-benzoazole Cyclometalated Iridium(III) dppz Complexes Exhibit Selective Phototoxicity in Cancer Cells by Lysosomal Damage and Oncosis.
Journal: Journal of medicinal chemistry
Published: December 23, 2023
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity.
Journal: Chemico-biological interactions
Published: August 08, 2023
Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death.
Journal: Angewandte Chemie (International ed. in English)
Published: July 27, 2023
Last Updated: 09/26/2026